BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20057161)

  • 1. Impact of blood pressure and other components of the metabolic syndrome on the development of cardiovascular disease.
    Kang G; Guo L; Guo Z; Hu X; Wu M; Zhou Z; Zhou H; Liu S; Chen F
    Circ J; 2010 Mar; 74(3):456-61. PubMed ID: 20057161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
    Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
    BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interactions among metabolic syndrome components on the development of cardiovascular disease among Kazakhs in Xinjiang.
    Yang W; Gao X; Zhang X; Hu Y; Guo H; Wang K; Yan Y; He J; Zhang J; Ma J; Mao L; Mu L; Liu J; Li S; Ding Y; Zhang M; Ma R; Guo S
    PLoS One; 2018; 13(10):e0205703. PubMed ID: 30325976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic interactions between cardiovascular risk factors.
    Vishram JK
    Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
    Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
    Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
    Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association and interaction between the components of metabolic syndrome and cardiovascular disease].
    Guo L; Hu XS; Guo ZR; Kang GD; Wu M; Zhou H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):644-7. PubMed ID: 19961740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project.
    Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z
    BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic disorders increase the risk to incident cardiovascular disease in middle-aged and elderly Chinese.
    Zhang ML; Hou XH; Zhu YX; Lu JX; Peng LP; Gu HL; Jia WP
    Biomed Environ Sci; 2012 Feb; 25(1):38-45. PubMed ID: 22424625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High normotension is associated with future metabolic syndrome but not cardiovascular disease: A 10-year longitudinal study.
    Chen YL; Hsu CH; Hsieh CH; Wu CZ; Lin JD; Chang JB; Liang YJ; Tsai YT; Hsia TL; Pei D
    Medicine (Baltimore); 2017 Jun; 96(25):e7227. PubMed ID: 28640118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender discrepancy in the predictive effect of metabolic syndrome and its components on newly onset cardiovascular disease in elderly from rural China.
    Yu S; Guo X; Li G; Yang H; Zheng L; Sun Y
    BMC Geriatr; 2021 Sep; 21(1):505. PubMed ID: 34563137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Lp-PLA2 levels add prognostic information to the metabolic syndrome on incidence of cardiovascular events among middle-aged nondiabetic subjects.
    Persson M; Hedblad B; Nelson JJ; Berglund G
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1411-6. PubMed ID: 17431184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal fasting plasma glucose predicts type 2 diabetes and cardiovascular disease in elderly population in Taiwan.
    Huang CL; Chang HW; Chang JB; Chen JH; Lin JD; Wu CZ; Pei D; Hung YJ; Lee CH; Chen YL; Hsieh CH
    QJM; 2016 Aug; 109(8):515-22. PubMed ID: 26576838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
    Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.